The ideal drug delivery system has a bioavailability comparable to parenteral dosage forms
but is as convenient and easy to use for the patient as oral solid dosage forms. In recent …

A microneedle (MN) is a painless and minimally invasive drug delivery device initially
developed in 1976. As microneedle technology evolves, microneedles with different shapes …

Melanoma remains a global concern, but current therapies present critical limitations
pointing out the urgent need for novel strategies. Among these, the cutaneous delivery of …

Transdermal delivery provides numerous benefits over conventional routes of
administration. However, this strategy is generally limited to a few molecules with specific …

Methicillin-resistant Staphylococcus aureus (MRSA) is a prevailing bacterial pathogen
linked to superficial skin and soft tissue infections (SSTIs). Rifampicin (RIF), a potent …

Drug delivery through the skin has immense advantages compared to other routes of
administration and offers an optimal way to treat inflammatory skin diseases, where …

Microneedles are gaining popularity as a new paradigm in the area of transdermal drug
delivery for biomedical and healthcare applications. Efficient drug delivery with minimal …

Drug-carrying nanoparticles have obtained great attention for disease treatments due to the
fact that they can improve drug solubility, provide drug protection and prolong release …

During the past decades, the advent of different microneedle patch (MNPs) systems paves
the way for the targeted and efficient delivery of several growth factors into the injured sites …

Transdermal drug delivery (TDD) was initially limited to fewer therapeutic agents due to the
requirements of suitable physicochemical and biological properties for passage across the …